We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
-14.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.83B
AUM Growth
-$682M
Cap. Flow
-$127M
Cap. Flow %
-4.47%
Top 10 Hldgs %
29.76%
Holding
486
New
59
Increased
45
Reduced
264
Closed
40

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$65.1M
2
INTU icon
Intuit
INTU
+$48.1M
3
BAX icon
Baxter International
BAX
+$33.7M
4
HLT icon
Hilton Worldwide
HLT
+$24.8M
5
CRM icon
Salesforce
CRM
+$20M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Healthcare 16.08%
3 Consumer Discretionary 15.15%
4 Industrials 13.19%
5 Financials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALO icon
226
Halozyme
HALO
$11.6B
$240K 0.01%
16,380
-400
-2% -$6.38K
BRSS
227
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$236K 0.01%
9,392
HRTX icon
228
Heron Therapeutics
HRTX
$63.4M
$231K 0.01%
8,910
GOL
229
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$229K 0.01%
16,885
AROW icon
230
Arrow Financial
AROW
$644M
$226K 0.01%
8,174
SYBT icon
231
Stock Yards Bancorp
SYBT
$2.58B
$226K 0.01%
6,895
THFF icon
232
First Financial Corp
THFF
$962M
$224K 0.01%
5,576
LXFR icon
233
Luxfer Holdings
LXFR
$457M
$221K 0.01%
12,515
-1,020
-8% -$23.2K
ANGO icon
234
AngioDynamics
ANGO
$651M
$219K 0.01%
10,871
APEI icon
235
American Public Education
APEI
$869M
$216K 0.01%
7,576
PCOM
236
DELISTED
Points.com Inc. Common Shares
PCOM
$216K 0.01%
21,692
-25
-0.1% -$296
IMMU
237
DELISTED
Immunomedics Inc
IMMU
$214K 0.01%
14,970
-200
-1% -$3.97K
MYGN icon
238
Myriad Genetics
MYGN
$311M
$212K 0.01%
7,290
-200
-3% -$7.2K
MOV icon
239
Movado Group
MOV
$817M
$211K 0.01%
6,684
ARNA
240
DELISTED
Arena Pharmaceuticals Inc
ARNA
$209K 0.01%
5,370
-200
-4% -$7.85K
FOLD
241
DELISTED
Amicus Therapeutics
FOLD
$201K 0.01%
20,960
-900
-4% -$9.89K
GBT
242
DELISTED
Global Blood Therapeutics, Inc.
GBT
$200K 0.01%
4,860
NVMI
243
Nova
NVMI
$12.2B
$198K 0.01%
8,687
-7
-0.1% -$166
VVX icon
244
V2X
VVX
$2.6B
$190K 0.01%
8,793
ACAD icon
245
Acadia Pharmaceuticals
ACAD
$5.06B
$188K 0.01%
+11,640
New +$226K
RDNT icon
246
RadNet
RDNT
$6.08B
$187K 0.01%
18,358
DX
247
Dynex Capital
DX
$3.17B
$186K 0.01%
10,818
PTCT icon
248
PTC Therapeutics
PTCT
$6.23B
$184K 0.01%
+5,360
New +$193K
GSBC icon
249
Great Southern Bancorp
GSBC
$874M
$179K 0.01%
3,889
-5
-0.1% -$261
MIXT
250
DELISTED
MIX TELEMATICS LIMITED
MIXT
$175K 0.01%
11,151

Similar funds

Smith Group Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Smith Group Asset Management held 486 positions worth $2.83B, down 19% from $3.52B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Smith Group Asset Management withdrew a net $127M in Q4 2018, closing 40 positions and reducing 264 holdings. Its most notable exit was Intuit, an estimated $48.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in Estee Lauder worth $27.9M.

  • Smith Group Asset Management's largest Q4 2018 buy was Estee Lauder: 214,550 shares worth $27.9M.
  • Smith Group Asset Management added most to Bristol-Myers Squibb in Q4 2018, an estimated $30.8M increase.
  • Smith Group Asset Management's biggest Q4 2018 reduction was Sysco, cutting an estimated $65.1M.
  • Smith Group Asset Management fully exited Intuit in Q4 2018, selling an estimated $48.1M.
  • Smith Group Asset Management's ten largest holdings make up 30% of its $2.83B portfolio in Q4 2018.
  • Smith Group Asset Management opened 59 new positions and closed 40 in Q4 2018.
  • Smith Group Asset Management's portfolio value fell 19% quarter-over-quarter to $2.83B.

Based on Smith Group Asset Management's 13F filing for Q4 2018, filed 6 Feb 2019.